Potency and duration of action of glucocorticoids
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, intermediate- or short-acting glucocorticoids—which have both a shorter biological half-life and lower glucocorticoid potency—are more likely to allow HPA recovery, provided that they are not administered at nighttime, when they can more pronouncedly inhibit ACTH production and the early-morning rise of endogenous cortisol (19, 79).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [19]
In the citing paper
“Prednisone and hydrocortisone have a wider variety of available doses and allow for a more gradual taper in smaller decrements, thus potentially enabling HPA axis to recover (19, 80).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [19]
Citations
Cites
Statistical Method in Biological Assay.
Healy, M. J. R., & Finney, D. J. (1979) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982559 · Cited by 3,586
Statistical Method in Biological Assay.
Barton, D. E., & Finney, D. J. (1966) · Biometrika · doi:10.2307/2334099 · Cited by 813
MELBY, J. C. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-505 · Cited by 222
Studies on Dexamethasone Metabolism in Man: Effect of Diphenylhydantoin
HAQUE, N., THRASHER, K., WERK, E. E., KNOWLES, H. C., & SHOLITON, L. J. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-1-44 · Cited by 139
Decreased Clearance of Prednisolone, a Factor in the Development of Corticosteroid Side Effects
KOZOWER, M., VEATCH, L., & KAPLAN, M. M. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-407 · Cited by 138
BALLARD, P. L., CARTER, J. P., GRAHAM, B. S., & BAXTER, J. D. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-2-290 · Cited by 135
The Site of the Suppressive Action of Dexamethasone on Pituitary-Adrenal Activity
DE KLOET, E. R., DER VIES, V. J., & DE WIED, D. (1974) · Endocrinology · doi:10.1210/endo-94-1-61 · Cited by 119
Nelson, D. H., Sandberg, A. A., Palmer, J. G., & Tyler, F. H. (1952) · Journal of Clinical Investigation · doi:10.1172/jci102671 · Cited by 119
WEST, C. D., MAHAJAN, D. K., CHAVRÉ, V. J., NABORS, C. J., & TYLER, F. H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-6-1230 · Cited by 116
Studies on dexamethasone, a new synthetic steroid, in rheumatoid arthritis—a preliminary report
Bunim, J. J., Black, R. L., Lutwak, L., Peterson, R. E., & Whedon, G. D. (1958) · Arthritis & Rheumatism · doi:10.1002/art.1780010404 · Cited by 112
Research works printed but not linked: 2
- Melby, 1959, Assessment of adrenocorticotropic activity with bacterial pyrogen in hypopituitary states (abstract), J Clin Invest, 38, 1025
- Meikle, 1976, Cushing's syndrome resulting from a low dose of dexamethasone, JAMA, 235, 1592, 10.1001/jama.1976.03260410048024 · doi:10.1001/jama.1976.03260410048024
Cited by
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
“pression were correlated with an increased frequen- ence the duration of effect and obscure drug potency of infections,[235] neoplasms[236,237] and athero- cy.[243] The influence of both factors (CE50 and drug sclerosis.”
BackgroundWaljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
Glucocorticoids in T Cell Development and Function
Ashwell, J. D., Lu, F. W. M., & Vacchio, M. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.309 · Cited by 782
Edlmann, E., Giorgi-Coll, S., Whitfield, P. C., Carpenter, K. L. H., & Hutchinson, P. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0881-y · Cited by 729
“%) and high potency but a relatively short plasma half-life of 4 – 4.7 h [95, 115].”
InfluentialGlucocorticoid use in acute lymphoblastic leukaemia
Inaba, H., & Pui, C.-H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70114-5 · Cited by 367
Metadata
- Authors
- Meikle, A. W., & Tyler, F. H.
- Corresponding author
- Meikle, A.Wayne
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1977-08
- Volume
- 63
- Issue
- 2
- Pages
- 200-207
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2020190536
- Cited by
- 319
- References
- 40
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 11 · 2023: 10 · 2022: 17 · 2021: 17 · 2020: 19 · 2019: 17 · 2018: 9 · 2017: 16 · 2016: 3 · 2015: 14 · 2014: 12 · 2013: 13 · 2012: 8
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, relative potency, dexamethasone, prednisone, cortisol, prednisolone, plasma corticosterone, plasma clearance, oral administration, duration of action
- MeSH terms
- Adult, Corticosterone, Depression, Chemical, Dexamethasone, Dose-Response Relationship, Drug, Female, Glucocorticoids, Half-Life, Humans, Hydrocortisone, Male, Pituitary-Adrenal System, Prednisone, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potency and duration of action of glucocorticoids. https://app.cochat.ai/papers/10.1016/0002-9343(77)90233-9
- The paper
- Meikle, A. W., & Tyler, F. H. (1977). Potency and duration of action of glucocorticoids. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(77)90233-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.